Chemotherapy for three months demonstrates lower side effects, suggesting its use as standard care compared with six months.

Induction chemotherapy shows significant improvements for survival in patients with locally advanced cervical cancer.

Dr. Jeff Watson, with Dynamic Spine and Neuropathy in Sioux Falls, is a leading expert in the field of chiropractics. He recently released a groundbreaking new book titled “A Patient’s ...

The new findings show that ADCs, just like chemotherapy, induce both tumor promoting as well as neuropathy inducing signals ...

Averitas Pharma, the US subsidiary of Grünenthal, has completed patient recruitment for the Phase III AV001 clinical study, ...

Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN) ...

A 57-year-old man suffering from debilitating pain, numbness, and difficulty walking found relief through immunotherapy, ...

A team of international researchers including those from the University of Adelaide have taken a well-known chemical reaction ...

A joint presentation by an endocrinologist and ophthalmologist reviewed best practices for managing thyroid eye disease, ...